The present invention relates to an
implant comprising: —a core material comprising
polydimethylsiloxane or at least one hydrogel
polymer; —a tube encasing said core material comprising an
ethylene vinyl acetate polymer or at least one hydrogel
polymer; —a
sealant for closure of the open ends of said tube comprising
polydimethylsiloxane or a mono-, di-, or triacetoxy derivative thereof, or at least one hydrogel polymer; and —at least one
active ingredient; wherein said at least one
active ingredient is selected from the group comprising
celecoxib,
sulindac,
tamoxifen, oestrogen, oestradiol, ethinyl oestradiol, mestranol, dienogest, norgestrel,
levonorgestrel, desogestrel, norgestimate,
ethynodiol diacetate,
leuprorelin, buserelin, gonrelin, triptorelin, nafarelin, deslorelin, histrelin, and supprelin; and with the proviso that when the
sealant is said at least one hydrogelpolymer, the core material comprises
polydimethylsiloxane. Furthermore, the invention relates to an
implant for use as a medicament. In particular, the invention relates to an
implant for use in the treatment of
endometriosis.